Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2003
08/28/2003WO2003070711A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
08/28/2003WO2003070710A1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
08/28/2003WO2003070277A1 Antipruritics
08/28/2003WO2003070254A1 Antibiotic conjugates
08/28/2003WO2003070244A1 Antagonist of melanin concentrating hormone and their uses
08/28/2003WO2003070236A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003WO2003045315A3 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
08/28/2003WO2003028641A3 Mch receptor antagonists
08/28/2003WO2003002559A3 Piperidine compounds for use as orexin receptor antagonist
08/28/2003US20030162979 Substituted sulphonylamino(thio)carbonyl compounds
08/28/2003US20030162972 Pyridyl alkane acid amides as cytostatics and immunosupressives
08/28/2003US20030162826 Degradation fragments
08/28/2003US20030162814 Amines such as 2-(3-(N-hydroxyamidino)phenylamino)-N-(2'-sulfamoylbiphenyl-4-yl)-2 -methylpropionamide, used as anticoagulants or for prophylaxis of arteriosclerosis, angina pectoris, restinosis or metastasis
08/28/2003US20030162812 4-haloalkyl-3-heterocyclylpyridines, 4-haloalkyl-5-heterocyclyl-pyrimidines and 4-trifluoromethyl-3-oxadiazolylpyridines, processes for their preparation, compositions comprising them, and their use as pesticides
08/28/2003US20030162794 Benzazole derivatives and their use as jnk modulators
08/28/2003US20030162791 Phenylpiperazines
08/28/2003US20030162787 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
08/28/2003US20030162780 Administering to a patient with a disease treatable with a muscarinic receptor antagonist a 1,2,3,4-tetrahydro-naphthalene-2-yl-alkylaminoalkyl-piperidine derivative
08/28/2003US20030162777 Administering a biheterocyclic compounds containing aminocarbonyl, aminothiocarbonyl or aminosulfonyl group for treating neuromuscular dysfunction of the lower urinary tract in a mammal in need of such treatment
08/28/2003US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
08/28/2003US20030162775 Heterocyclic substituted pyrazolones
08/28/2003US20030162766 Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists
08/28/2003US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use
08/28/2003US20030162661 Selective control of harmful plants in crops of useful plants
08/28/2003US20030161860 Novel substituted aryl alkenoic acid heterocyclic amides
08/28/2003CA2476822A1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003CA2476448A1 Antibiotic conjugates
08/28/2003CA2473100A1 Pyranones useful as atm inhibitors
08/28/2003CA2419685A1 Antidiabetic agents
08/27/2003EP1337531A2 Herbicidal heterocycles
08/27/2003EP1337530A1 Oxazolidinones having a benzannulated 6-or 7-membered heterocycle as antibacterial agents
08/27/2003EP1337526A1 Substituted imidazoles useful in the treatment of inflammatory diseases
08/27/2003EP1337524A1 Substituted quinolines as antitumor agents
08/27/2003EP1337513A1 4-substituted quinolines as antitumor agents
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337511A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
08/27/2003EP1337251A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
08/27/2003EP1165547B1 Substituted benzoylpyrazoles as herbicides
08/27/2003EP1140944B1 Epothilone derivatives and their use as antitumor agents
08/27/2003EP1087975B1 Epothilone minor constituents
08/27/2003EP1073672B1 Antipicornaviral compounds, their preparation and use
08/27/2003EP1007520B1 2-aminopyridines containing fused ring substituents as nos inhibitors
08/27/2003EP0785927B1 Novel benzoxazoles
08/27/2003CN1439007A 2-(3,5-disubstituted-4-pyridyl)-4(thienyl, thiazolylor arylphenyl)-1, 3-oxazoline compounds
08/27/2003CN1439004A Indole derivatives useful for treatment of CNS-disorders
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1439002A Muscarinic agonists
08/27/2003CN1438996A Bicyclic cyclohexylamines and their use NMDA receptor antogonists
08/27/2003CN1438890A 腺苷受体调制剂 Adenosine receptor modulators
08/27/2003CN1438220A 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/27/2003CN1119345C Benzo (5,6) cycloheptapyridine compounds use furl as farnesyl protein transferase inhibitors
08/27/2003CN1119149C 10,11 methanodibenzosuberane derivatives used as chemo sensitizing agents
08/26/2003US6610858 Antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex; thrombolytic agents
08/26/2003US6610731 Antiinflammatory
08/26/2003US6610730 Viricides; protease inbhibitor
08/26/2003US6610724 3-Aminopyrazole inhibitors of cyclin dependent kinases
08/26/2003US6610711 4-phenylpiperidines for the treatment of pruritic dermatoses
08/26/2003US6610707 Heterocyclic compounds as inhibitors of rotomase enzymes
08/26/2003US6610696 Such as 2-(4-(2-(2-(4-(3,5-dimethyl-isoxazol-4-yl)-phenyl)-5-methyloxazol-4-yl) -ethyoxy)-phenoxy)-2-methylpropionic acid for treatment of diabetes (lowering serum triglycerides)
08/26/2003US6610692 Anticoagulants
08/26/2003US6610687 Benzofuranylsulfonates
08/26/2003US6610680 Non-peptidyl vasopressin V1A antagonists
08/26/2003US6610631 Substituted aryl ketones
08/26/2003US6610518 Using Cytochrome p450
08/26/2003US6610323 An enteric coated pharmaceutical dosage form comprising an H+,K+- ATPase inhibitor is disclosed. The dosage form comprises at least two portions of the H+,K+- ATPase inhibitor to be released in at least two consecutive pulses.
08/21/2003WO2003068772A1 Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy
08/21/2003WO2003068771A1 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
08/21/2003WO2003068768A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
08/21/2003WO2003068767A1 Pyrimidines as novel openers of potassium ion channels
08/21/2003WO2003068766A1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
08/21/2003WO2003068760A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
08/21/2003WO2003068759A1 Piperazine derivatives as anti-inflammatory agents
08/21/2003WO2003068752A1 Benzenesulfonamide derivatives as antipsychotic agents
08/21/2003WO2003068751A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5-ht6 receptor affinity for the reatment of cns disorders
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068742A1 Synthesis of indole thiazole compounds as ligands for the ah receptor
08/21/2003WO2003068236A1 Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors
08/21/2003WO2003068230A1 Substituted pyridinones as modulators of p38 map kinase
08/21/2003WO2003068226A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
08/21/2003WO2003068220A1 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders
08/21/2003WO2003068170A2 Enzyme treatment of foodstuffs for celiac sprue
08/21/2003WO2003068140A2 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
08/21/2003WO2003067987A1 Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide
08/21/2003WO2003037890A3 Piperidines
08/21/2003WO2003024935A3 Substituted pyrazolyl compounds for the treatment of inflammation
08/21/2003US20030158424 Substituted alpha, beta-anellated butyrolactones
08/21/2003US20030158406 Enzyme inhibitor treating autoimmune diseases, Alzheimer's disease, atherosclerosis
08/21/2003US20030158405 N-benzhydryl indole compounds
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158233 Compositions and methods for treating heart failure
08/21/2003US20030158232 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
08/21/2003US20030158224 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents
08/21/2003US20030158205 N-benzyl-substituted, e.g., (2S)-1-(p-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(p -fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES
08/21/2003US20030158186 Compositions and methods for treating heart failure
08/21/2003US20030158182 Cyanopyrroles
08/21/2003US20030158177 Treating or preventing obesity
08/21/2003US20030158175 Chroman derivatives as 5-hydroxytrytamine-6 ligands
08/21/2003US20030158173 NK 1 antagonists
08/21/2003US20030158170 1-oxo-1,2,3,4- tetrahydronaphtho(1,2-f)(1,4)thiazepine compounds for use as antidepressants treating anxiety, stress, eating disorders, bipolar disorder, schizophrenic and psychotic disorders
1 ... 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 ... 647